News

Researchers from the University of California, Irvine, with assistance from the San Diego Supercomputer Center at UC San Diego, have found a new approach to the creation of customized therapies for virulent flu strains that resist current antiviral drugs. The findings, published online this week in Nature Communications, could aid development of new drugs that exploit so-called flu protein pockets.

It is the rare infection preventionist (IP) who has not daydreamed at some point about automating components of their infection prevention and control program by going live with an electronic surveillance system. It is also the rare IP who has not been surprised by some of what is involved with transitioning to such a system. This article aims to give you some tips on how to help assure a smooth transition, as well prepare you for what to expect for when you "go live."